Company profile
UK company 04581254, incorporated on 4 November 2002.
Sarissa Biomedical For A Better World
Sarissa Biomedical Limited is a UK company with status liquidation founded in 2002 based in South East England.
Company number 04581254
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
www.sarissa-biomedical.com A company that sells microelectrode biosensors for neurotransmitters and metabolites around the world. I am an inventor of the IP that underlies this company and founded it. Sarissa started to trade in 2005. Initially selling just biosensors for ATP, it then extended into other purines. Currently it sells biosensors for a total of 10 analytes -the most comprehensive range in the world, and has a collaborative agreement to provide biosensors for a company in the US (Pinnacle Technology).
We have used Sarissa's technology extensively in our MRC funded projects to measure both CO2 and glucose dependent ATP release. Sarissa's technology has featured in more than 50 scientific papers, including 18 that come from commercial customers that have no link to me. Many of these papers are in high impact journals such as Nature, Science, Neuron, Nature Medicine. Sarissa has so far run 3 workshops for new and prospective customers -these last a whole day and provide hands-on training and experience of using the biosensors with a number of different in vitro preps. All of the workshops have attracted visitors from overseas including North America and the EU.
1 Jul 2017 to 31 Aug 2019
To develop the capability to design, build and operate flexible, automated manufacturing technology for the volume production of In Vitro Diagnostic (IVD) Devices to address a global first to market opportunity.
1 Mar 2016 to 30 Nov 2016
Stroke affects 150,000 in the UK each year. It is the 3rd largest contributor towards premature death and the single biggest cause of acquired adult disability. The NHS currently spends £4.4bn on treating stroke patients with a further £5bn lost from the economy because one third of survivors need frequent assistance for personal care. Stroke is caused by...
1 Oct 2014 to 31 Mar 2015
Sarissa Biomedical develops & sells microelectronic (enzymatic) biosensors. Its devices are highly sensitive, selective & able to measure analytes in biological tissues & fluids such as unprocessed whole blood making them ideal for point of care diagnostics (PoC). Sarissa has identified a number of diseases where biomarkers have been proposed but the tech...
